Moomoo AI 已提取核心信息
Bruce Gerald W, the Chief Executive Officer of Virpax Pharmaceuticals, Inc. (VRPX), was involved in a transaction on January 29, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As the CEO of the company, Bruce Gerald W's transactions are closely watched by investors for insights into executive confidence in the company's performance and prospects.
Bruce Gerald W, the Chief Executive Officer of Virpax Pharmaceuticals, Inc. (VRPX), was involved in a transaction on January 29, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As the CEO of the company, Bruce Gerald W's transactions are closely watched by investors for insights into executive confidence in the company's performance and prospects.
Virpax Pharmicals, Inc.（VRPX）首席执行官布鲁斯·杰拉尔德·W于2024年1月29日参与了一笔交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。也没有提供交易的操作类型和状态。作为公司的首席执行官，Bruce Gerald W的交易受到投资者的密切关注，以深入了解高管对公司业绩和前景的信心。
Virpax Pharmicals, Inc.（VRPX）首席执行官布鲁斯·杰拉尔德·W于2024年1月29日参与了一笔交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。也没有提供交易的操作类型和状态。作为公司的首席执行官，Bruce Gerald W的交易受到投资者的密切关注，以深入了解高管对公司业绩和前景的信心。
有用
没用
